| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/07/2005 | US20050148078 Bovine immunodeficiency virus (BIV) based vectors |
| 07/07/2005 | US20050148077 Bovine immunodeficiency virus (BIV) based vectors |
| 07/07/2005 | US20050148076 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 07/07/2005 | US20050148075 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 07/07/2005 | US20050148072 Human liver progenitors |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148017 Antisense oligonucleotides against tenascin for the treating of vitiligo |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050147995 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 07/07/2005 | US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
| 07/07/2005 | US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics |
| 07/07/2005 | US20050147622 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 07/07/2005 | US20050147621 Use of bacterial 5' untranslated regions for nucleic acid expression |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147611 Combination therapy for conditions leading to bone loss |
| 07/07/2005 | US20050147608 modulating the activity of a nuclear factor kappa beta (NF-kB) polypeptide in cells by contacting with phosphoserine peptide or mimetics, for the treatment of cell proliferative disorders, immune response disorders and inflammatory disorders |
| 07/07/2005 | US20050147601 Angiogenesis inhibitor; wound healing agents; prevent cell adhesion in mallals |
| 07/07/2005 | US20050147597 Isolating autologous mononuclear cells and transplanting locally into injured tissue |
| 07/07/2005 | US20050147593 Targeting cells expressing low molecular weight protein tyrosine kinase (LMW-PTP) utilizing nucleic acid operatively associated with delivery vehicle |
| 07/07/2005 | US20050147592 Correcting underlying genetic defect; delivering heterologous gene encoding metabolic protein causing transduction of cells resulting in expression from transformed cell genetics |
| 07/07/2005 | US20050147591 Methods and compositions for viral enhancement of cell killing |
| 07/07/2005 | CA2551543A1 Method of suppressing cancer |
| 07/07/2005 | CA2551190A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | CA2550482A1 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 07/07/2005 | CA2550258A1 Oligomeric compounds for the modulation of bcl-2 |
| 07/07/2005 | CA2547338A1 Composition and methods for modulating cns activity |
| 07/07/2005 | CA2545777A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/07/2005 | CA2545696A1 An oncolytic adenovirus |
| 07/07/2005 | CA2543578A1 Genes commonly regulated by different classes of antidepressants |
| 07/07/2005 | CA2539169A1 A novel cationic lipopolymer as a biocompatible gene delivery agent |
| 07/06/2005 | EP1550722A1 Serotype of adenovirus and uses thereof |
| 07/06/2005 | EP1550719A1 Methods and medicament for inhibition the expression of a defined gene |
| 07/06/2005 | EP1550713A2 Gas driven gene delivery instrument |
| 07/06/2005 | EP1550463A1 Preparation for facilitating site-specific gene conversion and preparation for gene therapy |
| 07/06/2005 | EP1549760A2 Sak: modulation of cellular proliferation for treatment of cancer |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549755A2 Spliceosome mediated rna trans-splicing in stem cells |
| 07/06/2005 | EP1549751A2 Recombinant adenoviral vectors and applications thereof |
| 07/06/2005 | EP1549735A2 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 07/06/2005 | EP1549672A2 Ablated slam-dependent entry |
| 07/06/2005 | EP1549663A2 Multifunctional polypeptides |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549352A2 Methods for delivery of nucleic acids |
| 07/06/2005 | EP1549351A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/06/2005 | EP1549349A1 Non-viral gene delivery system |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1549340A1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 07/06/2005 | EP1549140A2 Production of peptides in plants as viral coat protein fusions |
| 07/06/2005 | EP1230375B1 Inhibiting gene expression with dsrna |
| 07/06/2005 | EP1222280B1 Apoptosis inducing proteinaceous substance |
| 07/06/2005 | EP1045902B1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/06/2005 | EP1017837B1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/06/2005 | EP0776327B1 New multimerizing agents |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636059A Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
| 07/06/2005 | CN1636053A Transplantation of haematopoietic cells |
| 07/06/2005 | CN1636018A 组织特异性表达 Tissue-specific expression |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1636010A Compositions for DNA mediated gene silencing |
| 07/06/2005 | CN1635905A Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 07/06/2005 | CN1635902A Remedy for infections |
| 07/06/2005 | CN1635898A Super-active porcine growth hormone releasing hormone analog |
| 07/06/2005 | CN1635120A ALBSIN/IL-18MAT hybridization cytokine |
| 07/06/2005 | CN1634985A Pig Ghrelin derivative, its encoding gene and application |
| 07/06/2005 | CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby |
| 07/06/2005 | CN1634610A Medical cornea paster and its preparation method |
| 07/06/2005 | CN1634597A Implanting device with anti-DNA lgM-DNA compound and preparation method thereof |
| 07/06/2005 | CN1634596A Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 07/06/2005 | CN1634595A Tie2 receptor mediated gene transfer system for targeted tumor gene therapy |
| 07/06/2005 | CN1634594A MAGE-1 and IL-18 co-expression gene vaccine and its construction method |
| 07/06/2005 | CN1634578A Leptospirosis vaccine and its use |
| 07/06/2005 | CN1209164C Compositions comprising DNA damaging agents and P53 |
| 07/05/2005 | US6914148 Monomer for use in huaman therapeutics and diagnostics |
| 07/05/2005 | US6914136 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo |
| 07/05/2005 | US6914134 Feline calicivirus genes and vaccines in particular recombinant vaccines |
| 07/05/2005 | US6914124 Tetracycline-regulated transcriptional activator fusion proteins |
| 07/05/2005 | US6914047 Secreted protein HEMAE80 |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913925 Producing conditionally-immortalized brain tissues for treatment of parkinson's and nervous system disorders |
| 07/05/2005 | US6913923 Virus envelope vector for gene transfer |
| 07/05/2005 | US6913922 Serotype of adenovirus and uses thereof |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913891 Comprises myeloid terminal differentiation (MYD) polypeptide for diagnosis and treatment of leukemia and cell proliferative disorders; antisense agents |
| 07/05/2005 | US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines. |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 06/30/2005 | WO2005059564A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2005 | WO2005059515A2 Method for treating neurological disorders |
| 06/30/2005 | WO2005059137A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 06/30/2005 | WO2005059135A2 Treatment of mammals by sirna delivery into mammalian nerve cells |
| 06/30/2005 | WO2005059123A2 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders |
| 06/30/2005 | WO2005059120A1 Methods of preventing transplantation rejection by creating immunologically neutral stem cells using gene silencing technology |
| 06/30/2005 | WO2005059113A1 Stem cells |
| 06/30/2005 | WO2005059111A2 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2005058369A2 Compositions of l-caldesmon for treating viral infection |
| 06/30/2005 | WO2005058368A1 Methods and compositions for treatment of interferon-resistant tumors |